Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35,258,614
-
Total 13F shares
-
2,512,086
-
Share change
-
+707,458
-
Total reported value
-
$49,594,000
-
Price per share
-
$4.68
-
Number of holders
-
27
-
Value change
-
+$41,200,982
-
Number of buys
-
18
-
Number of sells
-
9
Institutional Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q1 2021
As of 31 Mar 2021,
Anixa Biosciences Inc - Common Stock (ANIX) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,512,086 shares.
The largest 10 holders included
VANGUARD GROUP INC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Bank of New York Mellon Corp, NORTHERN TRUST CORP, RAYMOND JAMES & ASSOCIATES, JANE STREET GROUP, LLC, Spire Wealth Management, and Wealth Alliance Advisory Group, LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.